Envista Holdings 下调了 2025 财年的盈利指引，但第三季度超出预期，股价上涨。 Envista Holdings lowers FY 2025 earnings guidance, yet Q3 beats expectations, shares rise.

牙科产品公司Envista Holdings将其2025财政年度收入指导更新为0.950-1.050 EPS,低于分析师预计的1.120 EPS。 Dental products company Envista Holdings updated its FY 2025 earnings guidance to 0.950-1.050 EPS, below analyst expectations of 1.120 EPS. 尽管如此,Envista报告说,Q3 EPS为0.24美元,击败了预期的0.23美元。 Despite this, Envista reported a Q3 EPS of $0.24, beating the expected $0.23. 股票升至20.58美元,交易额为4 921 988美元。 Shares rose to $20.58 with 4,921,988 traded. 分析师的前景好坏参半, " 稳住 " 评级一致,目标价格为20.21美元。 Analysts have a mixed outlook, with a consensus "Hold" rating and a target price of $20.21. Envista在美国、中国和国际上都经营牙科产品。 Envista operates in dental products across the U.S., China, and internationally.